Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Supramarginal Resection in Patients With Glioblastoma: A Randomised Controlled Trial

NCT04243005 is registered in ClinicalTrials.gov with St. Olavs Hospital as lead sponsor.

NCT NCT04243005
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04243005 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Supramarginal Resection in Patients With Glioblastoma: A Randomised Controlled Trial
Lead sponsor
St. Olavs Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
July 1, 2020
Completion date
December 1, 2030
Enrollment
90 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma